Lianjun Zhang

5PUBLICATIONS
35CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|May 12, 2026
Targeting PRMT9 overcomes venetoclax resistance in AML by modulating splicing and inhibiting translation.

|Apr 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growth.

Melissa Valerio, Wenyuan Wei, Hyunjun Kang

|Dec 15, 2025
Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia.

Lianjun Zhang, HyunJun Kang, Melissa Valerio

Pageof 1

Frequent Collaborators

4 joint publications

Ya-Huei Kuo

2 joint publications

Le Xuan Truong Nguyen

2 joint publications

Guido Marcucci

2 joint publications

J Jefferson P Perry

2 joint publications

Weidong Hu

2 joint publications

Jianjun Chen

2 joint publications

Patrick Pirrotte

2 joint publications

Yu-Hsuan Fu

2 joint publications

Zhenhua Chen

2 joint publications

Bin Zhang

Frequent Collaborators

4 joint publications

Ya-Huei Kuo

2 joint publications

Le Xuan Truong Nguyen

2 joint publications

Guido Marcucci

2 joint publications

J Jefferson P Perry

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us